GlassScriptPhysician profile
Gwen A Urs
NPI 1942358288
$529.99
in general payments reported to CMS, 2019-2025
9 companies · $330 in 2025
The $330 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $19.77 · 2024: $181 · 2025: $330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $529.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $149.49 | 2025 | Prospera |
| Boston Scientific Corporation | $106.64 | 2023-2024 | |
| Averitas Pharma INC. | $78.67 | 2024-2025 | Qutenza |
| Collegium Pharmaceutical, INC. | $69.28 | 2024-2025 | Belbuca |
| Mml US, INC. | $34.39 | 2025 | Reactiv8 |
| Bioventus LLC | $25.21 | 2024 | Durolane |
| Globus Medical, INC. | $23.60 | 2025 | Senza |
| Acera Surgical, INC. | $22.79 | 2025 | Restrata Wound Matrix |
| Nalu Medical, INC. | $19.92 | 2024 | Nalu Neurostimulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gwen Urs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.